Font size
Background and font color
Images
Text scoring
Regular version of the site
En
+7 (495) 937 56 08
+7 (495) 937 56 08
Email
info@raifarm.com
The address
4 Malaya Dmitrovka, 4th Floor, office 8
Moscow, Russia, 127006

«In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
Our Company
  • About us
  • Our Achievements
  • Our Team
  • Our History
  • Careers
  • Documents
Our services
  • Drug Registration
  • Medical Devices Registration
  • GMP
  • Pharmacovigilance
  • Consulting
  • Drug registration
  • Medical devices registration
  • GMP
  • Pharmacovigilance
  • Consulting
Prices
News
Clients
Contact Us
en
ru Cn
en
En
Our Company
  • About us
  • Our Achievements
  • Our Team
  • Our History
  • Careers
  • Documents
Our services
  • Drug Registration
  • Medical Devices Registration
  • GMP
  • Pharmacovigilance
  • Consulting
  • Drug registration
  • Medical devices registration
  • GMP
  • Pharmacovigilance
  • Consulting
Prices
News
Clients
Contact Us
    en
    ru Cn
    +7 (495) 937 56 08
    Email
    info@raifarm.com
    The address
    4 Malaya Dmitrovka, 4th Floor, office 8
    Moscow, Russia, 127006

    «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
    En
    Our Company
    • About us
    • Our Achievements
    • Our Team
    • Our History
    • Careers
    • Documents
    Our services
    • Drug Registration
    • Medical Devices Registration
    • GMP
    • Pharmacovigilance
    • Consulting
    • Drug registration
    • Medical devices registration
    • GMP
    • Pharmacovigilance
    • Consulting
    Prices
    News
    Clients
    Contact Us
      en
      ru Cn
      +7 (495) 937 56 08
      Email
      info@raifarm.com
      The address
      4 Malaya Dmitrovka, 4th Floor, office 8
      Moscow, Russia, 127006

      «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
      En
      Telephones
      +7 (495) 937 56 08
      Email
      info@raifarm.com
      The address
      4 Malaya Dmitrovka, 4th Floor, office 8
      Moscow, Russia, 127006

      «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
      En
      • en
        • Language
        • en
        • ru
      • Our Company
        • Our Company
        • About us
        • Our Achievements
        • Our Team
        • Our History
        • Careers
        • Documents
      • Our services
        • Our services
        • Drug Registration
        • Medical Devices Registration
        • GMP
        • Pharmacovigilance
        • Consulting
        • Drug registration
        • Medical devices registration
        • GMP
        • Pharmacovigilance
        • Consulting
      • Prices
      • News
      • Clients
      • Contact Us
      • Cabinet
      • +7 (495) 937 56 08
        • Telephones
        • +7 (495) 937 56 08
      • 4 Malaya Dmitrovka, 4th Floor, office 8
        Moscow, Russia, 127006

        «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
      • info@raifarm.com
      Home
      —
      News
      —Registration of Medical Devices — Official Statistics for 2018 Published

      Registration of Medical Devices — Official Statistics for 2018 Published

      Common
      20 May 2019
      Make an application on the website, we will contact you soon and answer all your questions.
      Ask a Question

      On April 25, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) held a board meeting to summarize its performance in 2018, including the release of data on the registration of medical devices. Since Government Decree No. 1416 entered into force in 2013, the number of registered devices has varied highly from year to year, as we mentioned last year at the Raifarm Conference on September 25 (http://raifarm.com/news/press-releases/medical-device-regulation-russia-eaeu).

      The published Roszdravnadzor data is available in the Service’s video (https://youtu.be/VYQOQS7_VvY).

      Screenshot from the Roszdravnadzor video presentation

      In 2018, a total of 1,342 medical devices were registered, which is 61 devices or 5% less than in 2017. In 2017, the number of registered devices was 62 devices (4.23%) lower than in 2016. The trend in the number of registered devices is decreasing (note the trend line in the chart below). In this case, the trend line is approximate and reflects the prognosis for the next period.


      The video does not mention the causes of the decline in the number of marketing authorizations issued, but it can be assumed that the increasing complexity of regulatory requirements is a major cause. Expert requests to provide documentation and information continue to grow in complexity, and require considerable efforts to prepare a comprehensive response.

      The requests focus primarily on technical, operational, and regulatory documentation, which must provided with the utmost precision. Inconsistencies in the technical documentation provided by manufacturers are another reason for issuing requests. Applicants have to spend considerable time looking for such inconsistencies, which can happen for many different reasons. The most common causes are simple typos or cases when manufacturers supplied a document for a previous version of the medical device. Experts also frequently issue requests for device labeling and packaging, and also require stability and aging test results for devices with an expiration date. Regulatory specialists are required to have an ever-increasing knowledge of this field and learn to navigate the tangled web of bureaucracy in registration-related legislation.

      Screenshot from the Roszdravnadzor video presentation

      The domestic/foreign ratio for medical devices is 60%/40%, respectively. In absolute numbers, this equals 805 registration certificates issued for domestic products and 537 certificates for imported products. No information is provided in the video on the numbers of medical devices registered per risk class.

      In 2018, according to the official Roszdravnadzor database, a total of 336 registration certificates (25% of the total number of certificates) were issued for foreign and domestic Class I devices, 517 registration certificates (39%) for Class IIa devices, 336 certificates (25%) for Class IIb devices, and 153 certificates (11%) for Class III devices.

      A 38% decrease in the number of registration denials in 2018 compared to 2017 is also noteworthy, although this is likely determined by the fact that many registration dossiers are returned to applicants at the first stage of examination before reaching the “substantive examination” procedure, rather than the efficacy of Roszdravnadzor’s new “simplifications.” For example, we may recall some applicants’ recent complaints regarding requests to provide license agreements for trademarks, which in some cases is simply impossible. The situation is the same with requests related to particular aspects of devices and the economic activity of companies, which confuse many foreign manufacturers. In both cases, the registration process reaches a dead end and the application file is returned to the applicant. Returning documents in this manner is not considered a registration denial.

      The chart below shows the number of marketing authorizations issued from 2007 to 2018 broken down by domestic and foreign devices. The green line indicates when Government Decree No. 1416 On the Approval of the Rules for State Registration of Medical Products entered into force. For 2017, the overall number of marketing authorizations, both domestic and imported, is indicated. A total of 1,403 marketing authorizations were issued.

      Overall, although the registration procedure for Class I medical devices and IVD was simplified in 2018, the regulatory environment related to registration still remains complex.

      Author:

      Mikhail Vinogradov
      Head of Regulatory Affairs (Medical Devices)

      Как известно, Соглашение о единых принципах и правилах обращения медицинских изделий в рамках Евразийского экономического союза (ЕАЭС) предполагает полный переход на регистрацию медицинских изделий по новым правилам начиная с 1 января 2022 года. Попробуем провести краткий обзор ситуации за полгода до старта работы новой системы:

      Согласно информационной системе за последние три года на регистрацию по новым правилам было подано 46 дел, а на начало июня 2021 года Единый реестр медицинских изделий, зарегистрированных в рамках ЕАЭС содержал 5 записей о зарегистрированных медицинских изделиях - все из них произведены компаниями, находящимися в странах ЕАЭС. Время рассмотрения дела о регистрации отличалось в зависимости от страны и составляло от 87 до 363 дней.

      Единый реестр уполномоченных организаций, имеющих право проводить исследования (испытания) медицинских изделий в целях их регистрации на сегодня содержит информацию о более чем 30 лабораториях, находящихся в России, Республике Беларусь, Казахстане, Киргизии и Армении. Большинство из лабораторий из данного списка, с которым нам удалось пообщаться готовы начать испытания согласно евразийским правилам или начать подготовку к ним.

      На наш вопрос о необходимости получения разрешения для ввоза медицинского изделия в начале этого года, нами был получен ответ от Росздравнадзора о том, что порядок ввоза медицинских изделий не установлен действующими нормативно-правовыми актами.

      Аудит системы менеджмента качества производителей является одним из основных нововведений для процедуры ЕАЭС и, как известно, является обязательным шагом для регистрации медицинских изделий 2Б и 3 классов риска. Напомним, что Росздравнадзор объявил о первой проведенной инспекции производства на предмет соответствия требованиям к внедрению, поддержанию и оценке системы менеджмента качества медицинских изделий в сентябре 2020 года.

      Согласно ответу Росздравнадзора на наш запрос, на проведение инспекций со стороны России уполномочены ФГБУ «Национальный институт качества» Росздравнадзора и ФГБУ «ВНИИИМТ» Росздравнадзора.

      Еще одним нововведением является требование проведения многоцентровых клинических испытаний с обязательным участием человека для медицинских изделий классов риска 2Б, 3 и имплантируемых медицинских изделий. На сегодняшний день, согласно данным Росздравнадзора, проводить клинические испытания по Евразийской системе аккредитованы 16 клиник. Напомним, что процедура регистрации, согласно правилам Евразийского союза, предполагает одноэтапную экспертизу и требует подачу клинических данных в составе регистрационного досье.  

      Команда Райфарм внимательно следит за развитием Евразийского регулирования обращения медицинских изделий для начала работы по новым правилам.

      Back to the list
      Our experts will answer any question of interest
      Ask a Question
      Our Company
      Our services
      Price
      News
      Clients
      Contact Us
      Disclaimer
      Accessibility
      +7 (495) 937 56 08
      +7 (495) 937 56 08
      Email
      info@raifarm.com
      The address
      4 Malaya Dmitrovka, 4th Floor, office 8
      Moscow, Russia, 127006

      «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
      info@raifarm.com
      4 Malaya Dmitrovka, 4th Floor, office 8
      Moscow, Russia, 127006

      «In case of messages related to the safety of Medicinal Products, please write to  safety@raifarm.com  »
      © 2025 Raifarm LLC. All rights reserved.
      Privacy Policy
      Home Company Services Prices Contacts News Cabinet